AstraZeneca Makes a Big Splash

Among Covid-19 vaccine candidates, the Oxford and AstraZeneca vaccine might be worthwhile to mention here. Their vaccine is going to deliver the genetic code for the spikes coming out of  the new coronavirus and generate an immune response to fight against coronavirus.

The generic code was developed from chimpanzees and showed minor side effect in humans in phase 1 and 2. Phase 3 clinical trials started with 30,000 participants in US in August and with 70,000 in the UK, Brazil and South Africa. Production estimate is that AstraZeneca will be able to produce 2 billion doses worldwide (Rivas, A., Loftus, P. & Cervantes, A., 2020, September 1; Deng & Walker, 2020, August 6).

Cite as:

Rachel Kim (2020, September 2). AstraZeneca makes a big splash, The Blue Ocean Management, retrieved from: